NHS England has moved to make some items with low effectiveness unavailable on GP prescriptions, in order to offer financial savings for CCGs and improve care.
The products in question have been shown to be minimally effective, to offer no benefit over cheaper options, or where their benefits were outweighed by potential safety concerns.
The news follows a consultation launched in November 2018 to assess which products should be removed. Advice on the suggested removals is issued in the form of guidance documents to Clinical Commissioning Groups (CCGs) around the best use of their resources.
Consultations and revisions to the guidance have occurred prior to this round, in 2017.
The items added in this revision of the guidance are:
- minocycline for acne
- needles for pre-filled and reusable insulin pens (costing over £5 for 100 needles)
- emollient bath and shower preparations for dry and pruritic skin conditions
- silk garments